Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

MAIPN4550

Millipore

Plaque à 96 puits Multiscreen®, membrane PVDF hydrophobe

pore size 0.45 μm, non-sterile

Synonyme(s) :

Hydrophobic 96-Well Plate, PVDF 96-Well Plate, PVDF Membrane Plate

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Code UNSPSC :
41104923
eCl@ss :
32039006
Nomenclature NACRES :
NB.22

Matériaux

PVDF membrane (hydrophobic)
acrylic
flat bottom wells

Niveau de qualité

400

Description

Non-sterile, clear 96-well filter plate with 0.45 um pore size Hydrophobic PVDF membrane for Avidin-biotin Linkages, DNA-binding Proteins, Protein Binding & PAMPA. Comes in a pack of 50.

Stérilité

non-sterile

Gamme de produits

MultiScreen®

Caractéristiques

hydrophobic
lid

Fabricant/nom de marque

MultiScreen®

Paramètres

50-250 μL sample volume (per well)

Technique(s)

parallel artificial membrane permeation assay (PAMPA): suitable

Surface de filtration

0.3 cm2

Taille de la plaque/du plateau

96 wells

Volume maximum des puits

300 μL

Volume de travail

50-250 μL

Matrice

Immobilon®-P

Dimension de pores

0.45 μm pore size

Type de liaison

high binding surface

Conditions d'expédition

ambient

Application

La plaque de filtration MultiScreen®-IP, 0,45 µm, transparente, non stérile a été utilisée :
  • Comme support de membrane artificielle et plaque de récupération dans les tests parallèles de perméation de membrane artificielle (PAMPA) pour déterminer la perméabilité des oximes
  • Dans le test ELISpot (Enzyme-Linked Immunospot)
  • Dans le test ELISPOT spécifique à l'hémocyanine de patelle (KLH) pour l'identification des cellules spécifiques de l'antigène (Ag)

Informations légales

Immobilon is a registered trademark of Merck KGaA, Darmstadt, Germany
MULTISCREEN is a registered trademark of Merck KGaA, Darmstadt, Germany

Vous ne trouvez pas le bon produit ?  

Essayez notre Outil de sélection de produits.

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

A C Belkina et al.
Journal of dental research, 99(7), 855-862 (2020-03-19)
Periodontitis (PD) is a common source of uncontrolled inflammation in obesity-associated type 2 diabetes (T2D). PD apparently fuels the inflammation of T2D and associates with poor glycemic control and increased T2D morbidity. New therapeutics are critically needed to counter the
Claudia Giesecke et al.
Journal of immunology (Baltimore, Md. : 1950), 200(12), 3981-3992 (2018-05-08)
There are currently limited insights into the progression of human primary humoral immunity despite numerous studies in experimental models. In this study, we analyzed a primary and related secondary parenteral keyhole limpet hemocyanin (KLH) immunization in five human adults. The
Hee Chun Jeong et al.
Bioorganic & medicinal chemistry, 17(17), 6213-6217 (2009-08-12)
A series of fluorinated oxime compounds was designed and synthesized in order to probe the effect of fluorine substitution on reactivation of inhibited acetylcholinesterase (AChE) by organophosphorus agents. Permeability measurements, using the Parallel Artificial Membrane Permeation Assays (PAMPA) method, were

Articles

Evaluation of the reproducibility of Parallel Artificial Membrane Permeation Assays (PAMPA)

This is a white paper on the Evaluation of the reproducibility of Parallel Artificial Membrane Permeation Assays (PAMPA) using MultiScreen® Filter Plates.

Membrane Integrity Test for Lipid-PAMPA Artificial Membranes

This is a protocol for a Membrane Integrity test for Lipid-PAMPA Artificial Membranes

Permeability & Solubility Analysis Workflow

Combining solubility & PAMPA assays streamlines drug permeability testing.

Permeability & Solubility Analysis Workflow

Combining solubility & PAMPA assays streamlines drug permeability testing.

Afficher tout

Protocoles

HDM-PAMPA with the MultiScreen Permeability Filter Plate

Assays that predict passive absorption of orally administered drugs have become increasingly important in the drug discovery process. As previously described by Faller and Kansy such assays provide rapid, low cost and automation friendly methods to measure a compound’s passive permeability.

HDM-PAMPA with the MultiScreen Permeability Filter Plate

Assays that predict passive absorption of orally administered drugs have become increasingly important in the drug discovery process. As previously described by Faller and Kansy such assays provide rapid, low cost and automation friendly methods to measure a compound’s passive permeability.

HDM-PAMPA with the MultiScreen Permeability Filter Plate

Assays that predict passive absorption of orally administered drugs have become increasingly important in the drug discovery process. As previously described by Faller and Kansy such assays provide rapid, low cost and automation friendly methods to measure a compound’s passive permeability.

HDM-PAMPA with the MultiScreen Permeability Filter Plate

Assays that predict passive absorption of orally administered drugs have become increasingly important in the drug discovery process. As previously described by Faller and Kansy such assays provide rapid, low cost and automation friendly methods to measure a compound’s passive permeability.

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique